Literature DB >> 27176856

The usefulness of rating scales in patients with schizophrenia.

W Wolfgang Fleischhacker1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27176856     DOI： 10.1111/acps.12588

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  3 in total

1.  The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.

Authors:  Søren D Østergaard; Leslie Foldager; Ole Mors; Per Bech; Christoph U Correll
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

2.  Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series.

Authors:  Sukhpreet Poonia; Mazen Sharaf; Ric M Procyshyn; Randal White; Reza Rafizadeh
Journal:  Can J Hosp Pharm       Date:  2022-07-04

3.  Bridging the Measurement Gap Between Research and Clinical Care in Schizophrenia: Positive and Negative Syndrome Scale-6 (PANSS-6) and Other Assessments Based on the Simplified Negative and Positive Symptoms Interview (SNAPSI).

Authors:  Søren D Østergaard; Mark G A Opler; Christoph U Correll
Journal:  Innov Clin Neurosci       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.